Novo Nordisk A/S (NVO)

52.50 +0.89 (+1.72%) USD  |  NYSE  |  Dec 24, 12:59
52.65 +0.15 (+0.29%) After-Hours: 13:59
More

Novo Nordisk SG&A Expense (TTM): 10.84B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Ascendis Pharma A/S 446.44M
Evaxion AS 6.00M
Regeneron Pharmaceuticals, Inc. 2.717B
Omeros Corp. 44.20M
Viking Therapeutics, Inc. 52.36M